Public Health Practice of Population-Based Birth Defects Surveillance Programs in the United States

Cara T Mai1, Russell S Kirby, Adolfo Correa

  • 1Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia (Dr Mai); College of Public Health, University of South Florida, Tampa (Dr Kirby); University of Mississippi Medical Center, Jackson (Dr Correa); and School of Public Health, University of Illinois at Chicago (Drs Rosenberg, Petros, and Fagen).

Insights

Most US states monitor birth defects through population-based surveillance systems, collecting vital data to guide public health actions and improve infant health outcomes. These systems track major malformations and other conditions, aiding in early intervention and prevention efforts.

Area of Science:

  • Public Health Surveillance
  • Reproductive Health
  • Pediatric Health

Background:

  • Birth defects are a major cause of infant mortality and disability in the US.
  • Existing state surveillance systems monitor birth defects, but a comprehensive review is lacking.

Purpose of the Study:

  • To assess current population-based birth defects surveillance practices across the United States.

Main Methods:

  • A survey was distributed by the National Birth Defects Prevention Network to all US birth defects surveillance programs.
  • The survey covered operational status, case ascertainment, data collection, utilization, and program challenges.
  • A 100% response rate was achieved through follow-up reminders.

Main Results:

  • 43 states conduct population-based birth defects surveillance, covering 80% of US live births.
  • Seventeen programs use active case-finding, while 26 use passive case-finding.
  • Active programs collect more extensive data, including family history and broader pregnancy outcomes.

Conclusions:

  • Population-level data from birth defects surveillance programs are crucial for public health initiatives.
  • Enhanced collaboration between state and national levels can improve data harmonization and program effectiveness.
Abstract

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
811
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
60
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Pedigree Analysis01:35

Pedigree Analysis

Overview
91.4K
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.9K